Aviso: Este site agrega dados públicos oficiais da FDA, ClinicalTrials.gov, PubMed e SEC EDGAR apenas para referência geral. Não constitui aconselhamento médico, diagnóstico, recomendação de tratamento ou aconselhamento de investimento.

PubMed

The Evolving Regulatory Paradigm of AI in MedTech: A Review of Perspectives and Where We Are Today.

PMID: 38528278 ·

K, a, r, e, n, , Z, h, o, u, ;, , G, i, n, n, y, , G, a, t, t, i, n, g, e, r

RevistaTherapeutic innovation & regulatory science
Ano
PMID38528278

Resumo

Artificial intelligence (AI)-enabled technologies in the MedTech sector hold the promise to transform healthcare delivery by improving access, quality, and outcomes. As the regulatory contours of these technologies are being defined, there is a notable lack of literature on the key stakeholders such as the organizations and interest groups that have a significant input in shaping the regulatory framework. This article explores the perspectives and contributions of these stakeholders in shaping t

Fonte oficial

Ver no PubMed →

Dados provenientes do PubMed / NCBI. Para consultar o texto integral e as informações mais recentes, recorra sempre ao registo oficial.

↑